Sujata Tyagi Dayal, Director at Emergent BioSolutions Inc. (EBS), sold 13,761 shares at $8.36 ($116K) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Scheduled sale ($116k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.36 | 12,781 | $107K | 92.4% |
| 2 | $8.94 | 980 | $9K | 7.6% |
| Total | $8.40 avg | 13,761 | $116K | 100% |